This document provides recommendations regarding the design, conduct, and evaluation of studies for the demonstration of palatability of veterinary medicinal products intended for treatment of individual animals.
Keywords: Palatability, voluntary acceptance, oral dosage forms, veterinary medicinal products.
Current version - effective from 28/01/2022
Guideline on the demonstration of palatability of veterinary medicinal products - Revision 1
English (EN) (265.68 KB - PDF)
Document history
Guideline on the demonstration of palatability of veterinary medicinal products
The objective of this guideline is to specify requirements for the design, conduct, and evaluation of palatability studies for all oral dosage forms of pharmaceutical veterinary medicinal products (VMP) where palatability is claimed.
English (EN) (144.65 KB - PDF)
Overview of comments received on guideline on the demonstration of palatability of veterinary medicinal products
English (EN) (249.37 KB - PDF)
Draft guideline on the demonstration of palatability of veterinary medicinal products
The objective of this guideline is to specify requirements for the design, conduct, and evaluation of palatability studies for all oral dosage forms of pharmaceutical veterinary medicinal products where palatability is claimed or regarded necessary as part of the efficacy evaluation.
English (EN) (101.12 KB - PDF)
Draft concept paper for a guideline on the demonstration of palatability of veterinary medicinal products
In companion animals, oral medicines are often formulated to mask the bitterness of a substance and/or to improve the acceptance of e.g. tablets offered from the bowl/hand or mixed into the food in order to improve owner compliance. In relation to veterinary medicine products, this often results in an applicant submitting an application for a “palatability” claim, which should be demonstrated by appropriate data.
English (EN) (59.29 KB - PDF)